YORK, Nov. 24, 2022 /PRNewswire/ -- The global
PCR technologies Market market is expected to reach USD 18.3 billion by 2027 from an estimated
USD 12.5 billion in 2022, at a CAGR
of 8.0% from 2022 to 2027. Market growth is mainly driven by the
rising incidence of target infectious diseases and genetic
disorders, continuous advancements in PCR technologies and
increasing investments. In addition, growing market penetration in
emerging countries are expected to offer growth opportunities for
players in the PCR technologies market.
Read the full report:
POC tests can greatly improve the management of infectious
diseases, especially in developing countries where access to timely
medical care is a challenge and the healthcare infrastructure is
antiquated and sparse. According to UNAIDS, around 20.6 million
people were living with HIV in East and Southern Africa in 2018. In 2019, 20,000 new
HIV cases were registered in the Middle
East and North Africa
(Source: UNAIDS Data 2020). In the Asia
Pacific, an estimated 5.8 million people were suffering from
HIV in 2019, led by India and
China. According to UNAIDS, in
2019, approximately 2.1 million people in India were infected with HIV. The high
prevalence of HIV is likely to boost the demand for point-of-care
diagnostics, further accelerating the treatment of HIV
Listed below are important statistics related to major
infectious diseases in developing countries:
According to the WHO, India has
the highest tuberculosis burden, with an estimated incidence of
2.64 million cases in 2020.
â€¢ In 2019, around 4.3 million new tuberculosis cases were
reported in Southeast Asia, and
632,000 people died due to TB infections in this region (Source:
â€¢ According to the National Influenza Policy 2017, around 10,000
deaths and 40,000 hospitalizations are caused due to influenza in
South Africa each year.
â€¢ According to the WHO, 1.2 million people in Southeast Asia suffer from malaria, with
India alone accounting for ~76% of
the total malaria cases.
â€¢ During 2014â€"2016, West
Africa reported the largest Ebola epidemic in the region; in
two and a half years, the outbreak resulted in more than 28,600
cases and 11,325 deaths.
â€¢ In 2020, an estimated 15,898 people in Brazil were at risk of Zika virus infections,
down from over 30,000 cases reported a year earlier.
The high prevalence of infectious diseases, coupled with the
inadequate healthcare infrastructural facilities in developing
countries, is expected to drive the adoption of POC testing.
The Reagents and Consumables segment accounted for the largest
share of the PCR technologies market, by product, in 2021
Based on products, the PCR technologies market is segmented into
instruments, reagents and consumables, and software and services.In
2021, the largest share of the PCR technologies market was
accounted by reagents and consumables segment, due to factors such
as the increased dPCR application base and developing demand for
dPCR based analytical procedures, among researchers and
Moreover, bundle sales of PCR reagents with the purchase of PCR
instruments and long term sales contract for PCR reagents upon
device upgradation is also a major factor driving the adoption of
PCR reagents and consumables in major markets.
The real-time PCR (qPCR) segment accounted for the largest share
of the PCR technologies market, by technique, in 2021
Based on technique, the PCR technologies market is segmented into
conventional PCR, real-time PCR (qPCR), digital PCR (dPCR), reverse
transcription PCR (RT-PCR), hot-start PCR, multiplex PCR, and other
PCR techniques.The real-time PCR (qPCR) segment accounted for the
largest share of the market in 2021.
Factors such as the ongoing automation of the laboratory
techniques; expansion of qPCR applications, owing to real-time
analysis and reduced analysis time; increased funding and
investments for qPCR based research, rising number of probe-based
multiplex genetic analysis procedures and large installation base
of qPCR instruments are expected to fuel the growth of the
real-time PCR market.
The Diagnostic application segment, by application, accounted
for the largest share of the global PCR technologies market in
On the basis of application, the PCR technologies market is
segmented into gene expression analysis, genetic sequencing,
genotyping, nucleic acid detection, nucleic acid synthesis,
standard validation/verification, diagnostic applications,
environmental applications, and other applications.The diagnostic
application segment accounted for the largest share of the market
Major factor responsible is the significant evolution from a
traditional DNA quantification technique into an advanced
diagnostic technique having various diagnostic applications, such
as prenatal screening test, rapid pathogen detection, disease
diagnoses and the identification of blood-borne diseases during
On the basis of End Users, Hospitals and Diagnostic Centers
segment accounted for the largest share of the global PCR
technologies market, in 2021
On the basis of end users, the PCR technologies market is segmented
into hospitals and diagnostic centers, healthcare industry,
academia and government organizations, pharma-biotech companies,
applied industries, and other end users.The hospitals and
diagnostic centers segment accounted for the largest share of the
PCR technologies market in 2021.
The rise in qPCR reagents market availability for clinical
diagnostics, ongoing healthcare infrastructure expansion in
emerging countries, and the continuous cost reduction of qPCR
reagents are some of the factors that are driving the segment.
The Asia Pacific market is
expected to grow at the highest CAGR during the forecast
The global PCR technologies market is segmented into North America, Europe, the Asia
Pacific, Latin America, and
the Middle East & Africa.In
2021, North America accounted for
the largest share of this market, followed by Europe.
However, the Asia Pacific is
expected to grow at the fastest CAGR during the forecast period.
The high growth of this segment is mainly due to the ongoing of
healthcare infrastructure expansion in emerging Asian countries,
increasing number of genomics and cancer research projects in
countries like China, India, and Japan, continuous government support for
genomics-based researches in emerging Asia Pacific countries and rising outsourcing
of clinical research by leading drug manufacturing companies to
A breakdown of the primary participants referred to for this
report is provided below:
â€¢ By Company Type: Tier 1â€"48%, Tier 2â€"36%, and Tier 3â€"
â€¢ By Designation: C-levelâ€"10%, Director-levelâ€"14%, and
â€¢ By Region: North Americaâ€"40%, Europeâ€"32%, Asia
Pacificâ€"20%, Latin Americaâ€"5%, and the Middle East & Africaâ€"3%
As of 2021, the PCR technologies market is dominated by Thermo
Fisher Scientific, Inc. (US), F. Hoffman-La Roche Ltd.
Laboratories, Inc. (US), QIAGEN N.V. (Germany), Takara
Bio, Inc. (Japan). Other
leading players are Agilent Technologies, Inc. (US), bioMÃ©rieux
S.A. (France), Fluidigm
Corporation (US), Danaher Corporation (US), Abbott Laboratories
(US), Merck KGaA (Germany),
Becton Dickinson and Company (US),
Promega Corporation (US), Eppendorf AG (Germany), and Analytik Jena AG (Germany).
This report studies the PCR technologies market based on product,
technique, application, end user and region.It also covers the
factors affecting market growth, analyzes the various opportunities
and challenges in the market, and provides details of the
competitive landscape for market leaders.
Furthermore, the report analyzes micromarkets with respect to their
individual growth trends and forecasts the revenue of the market
segments with respect to five main regions (and the respective
countries in these regions).
Reasons to Buy the Report
The report will enable established firms as well as
entrants/smaller firms to gauge the pulse of the market, which, in
turn, would help them to garner a larger market share. Firms
purchasing the report could use one or a combination of the
below-mentioned strategies for strengthening their market
This report provides insights on the following pointers:
â€¢ Market Penetration: Comprehensive information on the product
portfolios offered by the top players in the PCR technologies
â€¢ Product Development/Innovation: Detailed insights on the
upcoming trends, R&D activities, and product launches in the
PCR technologies market
â€¢ Market Development: Comprehensive information on lucrative
â€¢ Market Diversification: Exhaustive information about new
products, growing geographies, and recent developments in the PCR
â€¢ Competitive Assessment: In-depth assessment of market segments,
growth strategies, revenue analysis, and products of the leading
Read the full report:
ReportLinker is an award-winning market research solution.
Reportlinker finds and organizes the latest industry data so you
get all the market research you need - instantly, in one place.
Contact Clare: firstname.lastname@example.org
Intl: +1 339-368-6001